Literature DB >> 22278369

A proteome comparison between physiological angiogenesis and angiogenesis in glioblastoma.

Dana A M Mustafa1, Lennard J Dekker, Christoph Stingl, Andreas Kremer, Marcel Stoop, Peter A E Sillevis Smitt, Johan M Kros, Theo M Luider.   

Abstract

The molecular pathways involved in neovascularization of regenerating tissues and tumor angiogenesis resemble each other. However, the regulatory mechanisms of neovascularization under neoplastic circumstances are unbalanced leading to abnormal protein expression patterns resulting in the formation of defective and often abortive tumor vessels. Because gliomas are among the most vascularized tumors, we compared the protein expression profiles of proliferating vessels in glioblastoma with those in tissues in which physiological angiogenesis takes place. By using a combination of laser microdissection and LTQ Orbitrap mass spectrometry comparisons of protein profiles were made. The approach yielded 29 and 12 differentially expressed proteins for glioblastoma and endometrium blood vessels, respectively. The aberrant expression of five proteins, i.e. periostin, tenascin-C, TGF-beta induced protein, integrin alpha-V, and laminin subunit beta-2 were validated by immunohistochemistry. In addition, pathway analysis of the differentially expressed proteins was performed and significant differences in the usage of angiogenic pathways were found. We conclude that there are essential differences in protein expression profiles between tumor and normal physiological angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278369      PMCID: PMC3433895          DOI: 10.1074/mcp.M111.008466

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  36 in total

1.  Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.

Authors:  C L Gladson
Journal:  J Neuropathol Exp Neurol       Date:  1996-11       Impact factor: 3.685

Review 2.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

3.  Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.

Authors:  Dimpy Koul; Ruijun Shen; Sherry Bergh; Yiling Lu; John F de Groot; Ta Jen Liu; Gordon B Mills; W K Alfred Yung
Journal:  Mol Cancer Ther       Date:  2005-11       Impact factor: 6.261

4.  Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.

Authors:  Nuzhat Ahmed; Clyde Riley; Greg Rice; Michael Quinn
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 5.  EPCs and pathological angiogenesis: when good cells go bad.

Authors:  Sergio Li Calzi; Matthew B Neu; Lynn C Shaw; Jennifer L Kielczewski; Nicanor I Moldovan; Maria B Grant
Journal:  Microvasc Res       Date:  2010-02-25       Impact factor: 3.514

6.  Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry.

Authors:  Donald J Johann; Jaime Rodriguez-Canales; Sumana Mukherjee; DaRue A Prieto; Jeffrey C Hanson; Michael Emmert-Buck; Josip Blonder
Journal:  J Proteome Res       Date:  2009-05       Impact factor: 4.466

Review 7.  Integrin and growth factor receptor alliance in angiogenesis.

Authors:  Payaningal R Somanath; Alieta Ciocea; Tatiana V Byzova
Journal:  Cell Biochem Biophys       Date:  2008-12-02       Impact factor: 2.194

Review 8.  Proteomics in atherosclerosis.

Authors:  Roxana Martinez-Pinna; Jose Luis Martin-Ventura; Sebastian Mas; Luis Maria Blanco-Colio; Jose Tuñon; Jesus Egido
Journal:  Curr Atheroscler Rep       Date:  2008-06       Impact factor: 5.113

9.  Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression.

Authors:  Keiichiro Tanaka; Noriko Hiraiwa; Hisashi Hashimoto; Yoji Yamazaki; Moriaki Kusakabe
Journal:  Int J Cancer       Date:  2004-01-01       Impact factor: 7.396

10.  Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.

Authors:  Go Takayama; Kazuhiko Arima; Taisuke Kanaji; Shuji Toda; Hiroyuki Tanaka; Shunsuke Shoji; Andrew N J McKenzie; Hiroichi Nagai; Takao Hotokebuchi; Kenji Izuhara
Journal:  J Allergy Clin Immunol       Date:  2006-04-27       Impact factor: 10.793

View more
  15 in total

1.  Periostin is a novel therapeutic target that predicts and regulates glioma malignancy.

Authors:  Andrei M Mikheev; Svetlana A Mikheeva; Andrew D Trister; Mari J Tokita; Samuel N Emerson; Carolina A Parada; Donald E Born; Barbara Carnemolla; Sam Frankel; Deok-Ho Kim; Rob G Oxford; Yoshito Kosai; Kathleen R Tozer-Fink; Thomas C Manning; John R Silber; Robert C Rostomily
Journal:  Neuro Oncol       Date:  2014-08-19       Impact factor: 12.300

2.  Single Cell Immuno-Laser Microdissection Coupled to Label-Free Proteomics to Reveal the Proteotypes of Human Brain Cells After Ischemia.

Authors:  Teresa García-Berrocoso; Víctor Llombart; Laura Colàs-Campàs; Alexandre Hainard; Virginie Licker; Anna Penalba; Laura Ramiro; Alba Simats; Alejandro Bustamante; Elena Martínez-Saez; Francesc Canals; Jean-Charles Sanchez; Joan Montaner
Journal:  Mol Cell Proteomics       Date:  2017-11-13       Impact factor: 5.911

Review 3.  The Microenvironmental Landscape of Brain Tumors.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Cancer Cell       Date:  2017-03-13       Impact factor: 31.743

Review 4.  Role of tenascins in the ECM of gliomas.

Authors:  Nicole Brösicke; Andreas Faissner
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

5.  miR-218 affects the ECM composition and cell biomechanical properties of glioblastoma cells.

Authors:  Małgorzata Grabowska; Konrad Kuczyński; Monika Piwecka; Alicja Rabiasz; Joanna Zemła; Paweł Głodowicz; Dariusz Wawrzyniak; Małgorzata Lekka; Katarzyna Rolle
Journal:  J Cell Mol Med       Date:  2022-06-15       Impact factor: 5.295

6.  A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression.

Authors:  Peng Zhang; Zhengguang Guo; Yang Zhang; Zhixian Gao; Nan Ji; Danqi Wang; Lili Zou; Wei Sun; Liwei Zhang
Journal:  Proteome Sci       Date:  2015-03-12       Impact factor: 2.480

7.  Release of endothelial cell associated VEGFR2 during TGF-β modulated angiogenesis in vitro.

Authors:  M Jarad; E A Kuczynski; J Morrison; A M Viloria-Petit; B L Coomber
Journal:  BMC Cell Biol       Date:  2017-01-23       Impact factor: 4.241

8.  Candidate biomarker discovery for angiogenesis by automatic integration of Orbitrap MS1 spectral- and X!Tandem MS2 sequencing information.

Authors:  Mark K Titulaer
Journal:  Genomics Proteomics Bioinformatics       Date:  2013-04-02       Impact factor: 7.691

Review 9.  Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.

Authors:  Laure Malric; Sylvie Monferran; Julia Gilhodes; Sabrina Boyrie; Perrine Dahan; Nicolas Skuli; Julie Sesen; Thomas Filleron; Aline Kowalski-Chauvel; Elizabeth Cohen-Jonathan Moyal; Christine Toulas; Anthony Lemarié
Journal:  Oncotarget       Date:  2017-08-21

10.  Does a Better Perfusion of Deconditioned Muscle Tissue Release Chronic Low Back Pain?

Authors:  Paola Valdivieso; Martino V Franchi; Christian Gerber; Martin Flück
Journal:  Front Med (Lausanne)       Date:  2018-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.